Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.
暂无分享，去创建一个
[1] K. Tanikawa,et al. Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif) , 2000 .
[2] Y. Shiratori,et al. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection , 1999, Hepatology.
[3] R. King,et al. The M539V Polymerase Variant of Human Hepatitis B Virus Demonstrates Resistance to 2′-Deoxy-3′-Thiacytidine and a Reduced Ability to Synthesize Viral DNA , 1998, Antimicrobial Agents and Chemotherapy.
[4] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .
[5] D. Tyrrell,et al. Mutation in HBV RNA‐dependent DNA polymerase confers resistance to lamivudine in vivo , 1996, Hepatology.
[6] R. Schinazi,et al. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] I Sauvaget,et al. Identification of four conserved motifs among the RNA‐dependent polymerase encoding elements. , 1989, The EMBO journal.